Seppo YlÄ-herttuala
Professor of Molecular Medicine
Department of Biotechnology and Molecular Medicine
University of Eastern Finland
Finland
Biography
He is working as an professor in Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
Research Interest
VEGF biology and therapeutic angiogenesis, pathogenesis and treatment of atherosclerosis and other vascular and ischemic diseases. Lentiviral, AAV and adenoviral technology, gene therapy, epigenetherapy.
Publications
-
Tytteli Anni Kaarina Turunen, Johanna Päivikki Laakkonen, Laura Alasaarela, Kari Juhani Airenne, Seppo Ylä-Herttuala (2014) Sleeping Beauty–baculovirus hybrid vectors for long-term gene expression in the eye. J Gene Med 16: 1521-2254.
-
Schenkwein D, Ylä-Herttuala S (2016) Development of Lentiviral Vectors for Targeted Integration and Protein Delivery. Methods Mol Biol 1448: 185-198.
-
Kivelä AM, Huusko J, Gurzeler E, Laine A, Ylä-Herttuala S, et al. (2017) High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy. Sci Rep 7: 386.
